Asieris Pharmaceuticals

company

About

Asieris Pharmaceuticals is a Chinese biotech company.

  • 101 - 250

Details

Last Funding Type
Series D
Last Funding Money Raised
¥700M
Industries
Biotechnology,Health Care,Medical,Pharmaceutical
Founded date
Jan 1, 2010
Number Of Employee
101 - 250
Operating Status
Active

Asieris Pharmaceuticals is a Chinese biotech company focusing on therapeutic areas in oncology and multidrug-resistant infections.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
¥1.09B
Asieris Pharmaceuticals has raised a total of ¥1.09B in funding over 2 rounds. Their latest funding was raised on Nov 11, 2020 from a Series D round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Nov 11, 2020 Series D ¥700M 3 Detail
Jun 28, 2020 Series C ¥290M 1 Detail
Dec 29, 2017 Series B ¥100M 1 Detail

Investors

Number of Lead Investors
Number of Investors
5
Asieris Pharmaceuticals is funded by 5 investors. Haoshuo Zhier Fund and IFSC are the most recent investors.
Investor Name Lead Investor Funding Round
Haoshuo Zhier Fund Series D
IFSC Series D
Homsun Capital Series D
Huayin Finance & Investment Series C
Phoenix Fund Series B